heart attack News
-
Auto exhaust linked to increased risk of heart attack
Swiss, California and Spanish researchers have found that particulates from auto exhaust can lead to the thickening of artery walls, possibly increasing chances of a heart attack and ...
-
Elucid’s Next-Generation Plaque Analysis and FFRCT Technology to be Featured on 2022 AHA Scientific Sessions Program
BOSTON – November 4, 2022 – Elucid, Inc., a medical technology company providing physicians AI-powered imaging analysis software to characterize cardiovascular disease, has announced that the company’s technology will be featured on the program at the 2022 American Heart Association (AHA) Scientific Sessions, November 5-7, 2022 in Chicago. Elucid has developed FDA-cleared ...
By Elucid
-
Blood ties: The inspiration behind a potential sepsis breakthrough
Robert Hancock and Olga Peña—who lost her father to sepsis—may have found a way to diagnose the deadliest syndrome you’ve never heard of. The doctor suspected 70-year-old Augustin Peña had the flu, so he sent him home to rest and drink lots of fluids. But after three days of continuing to suffer, Peña entered the local hospital in Tolima, Colombia. His ...
-
Pipelife around the world - Finland
In the course of our group-wide charity project, Pipelife Finland has divided its donation in two parts in order to support two organizations: the Northern Ostrobothnia Heart Association and the Save the Children Foundation. The Northern Ostrobothnia regional heart association is a part of the Finnish Heart Association and promotes heart health of the inhabitants of Northern Osthrobothnia. The ...
-
MEDIA ADVISORY: EPA to Hold Public Hearing in Arlington, Texas on Proposed Smog Standards
The U.S. Environmental Protection Agency (EPA) will hold a public hearing on the proposed updates to the national air quality standards for ground-level ozone, also known as smog. EPA has proposed to strengthen the standards to a level within a range of 65 to 70 parts per billion (ppb) to better protect Americans’ health and the environment, while taking comment on a level down to 60 ppb. ...
-
High temperatures in cities increase hospitalisation for the elderly
High summer temperatures have a clear impact on rates of admission to hospital for elderly patients with breathing problems, according to new research. Although data reveals considerable variation among cities across Europe, admission rates for respiratory causes among the 75+ age group were more than twice the admission rate for all ages in all cities. Data on hospital admissions, heat, ...
-
FAPI featured in accolades at annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting
Congratulations to investigators at Hannover School of Medicine and Heidelberg University Hospital for receiving the 2022 SNMMI Image of the Year Award and JNM Editors’ Choice Award for Overall Best Article in 2021, respectively. Both use FAPI as the primary indicator and further underscore its potential impact as a novel radiopharmaceutical. Each year, SNMMI chooses an image that best ...
By SOFIE
-
Miracor Medical granted FDA Breakthrough Device Designation for the PiCSO therapy
Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its PiCSO Impulse System for treatment of STEMI patients. The FDA Breakthrough Device designation is intended to speed time to market for treatments of life-threatening or irreversibly debilitating diseases or conditions and recognizes the novelty of the PiCSO ...
-
Bisphenol A exposure can increase risk of diabetes and heart attacks
In human fat tissues, bisphenol A (BPA) suppresses levels of a key hormone, adiponectin, that protects people from heart attacks and Type II diabetes. These results implicate BPA as a potential cause of metabolic syndrome, one of the most serious and costly public health problems in the US. Most Americans have levels of BPA within their serum within the range of concentrations sufficient to ...
-
BioVentrix Receives 2021 NUB Status 1 Reimbursement Renewal in Germany for the Revivent TC TransCatheter Ventricular Enhancement System
BioVentrix, Inc., a privately held medical device company focused on treating congestive heart failure (CHF) via Transcatheter based Ventricular Restoration (TCVR), today announced that the German Institute for Hospital Remuneration (InEK) has renewed the NUB Status 1 reimbursement designation in Germany for the Revivent TC™ TransCatheter Ventricular Enhancement System used in LIVE™ ...
-
EPA Releases New PSA for American Heart Month
Today, the U.S. Environmental Protection Agency (EPA) issued a new Public Service Announcement (PSA) to educate the public and healthcare providers about the risks of air pollution to the heart. "Over more than four decades of EPA history, we've made tremendous progress cleaning up the air we breathe by using science to understand the harmful effects of air pollution," said EPA Administrator ...
-
Elucid Raises $27 Million Series B Funding Round to Commercialize a New Paradigm in Heart Disease Diagnosis
BOSTON – June 22, 2022 – Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced the closing of a $27 Million Series B financing round. The round was led by an undisclosed strategic investor, with participation from Biovision Ventures, a new Europe-based fund, and existing investors, including MedTex ...
By Elucid
-
Corindus Completes First-Ever, Transcontinental Simulated Telerobotic Percutaneous Coronary Intervention Procedures Over 5G, Fiber, and Public Internet Networks
Corindus, a Siemens Healthineers company and a leading developer of precision vascular robotics, announced today it has completed the first multi-city, transcontinental percutaneous coronary intervention (PCI) simulations in the United States over three network connection types – 5G wireless, dedicated fiber, and commercial public internet networks. Interventional cardiologist Ryan Madder, ...
-
Revacept - an innovative vascular plaster proved in coronary heart disease
The novel drug Revacept can reduce heart attacks and strokes more efficient and safer than previous standard therapies. This is the result of a study in an investigator initiated study in patients carried out with the German Center for Heart and Circulation Research (DZHK). The study was recently published in JAMA Cardiology. With Revacept severe complications such as heart attacks and stroke in ...
-
EPA to Hold Public Hearings in California, Texas and D.C. on Proposed Smog Standards
The U.S. Environmental Protection Agency (EPA) will hold three public hearings on the proposed updates to the national air quality standards for ground-level ozone, also known as smog. EPA has proposed to strengthen the standards to a level within a range of 65 to 70 parts per billion to better protect Americans’ health and the environment, while taking comment on a level down to 60 ppb. ...
-
Studies suggest Elucid’s AI software helps to objectively quantify key drivers of stroke and heart attack from computed tomography angiography (CTA)
Computed tomography angiography (CTA) has been increasingly used in the diagnosis of vascular disease and its a modality that offers many potential clinical benefits. The question is, how to actualize that benefit and get the most our of the modality. Elucid has developed an artificial intelligence software that might just answer that question. How AI Can Improve CTA Analysis ...
By Elucid
-
World Thrombosis Day
On World Thrombosis Day, October 13, 2021, Emosis is proud to be a "messenger" of the "Eyes open to Thrombosis" information campaign. Eyes open to Thrombosis WTD is an educational campaign to raise awareness and educate the public to the importance of reducing death and disability from thrombosis. It is a global alliance of thousands of local, regional, national and international ...
-
Miracor Medical starts PiCSO-AMI-I randomized study in EU
Miracor Medical SA (Miracor Medical) today announced the initiation and first patient enrollment in the PICSO-AMI-I study to evaluate the benefits of PiCSO® therapy compared with conventional PCI for the treatment of anterior STEMI patients. The first patient enrolled into this study was treated at Oxford Heart Center, Oxford, UK by Professor Adrian Banning, the principal investigator of the ...
-
Robocath successfully carries out Europe’s first remote robotic-assisted coronary angioplasty
Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces the successful completion of the first remote robotic-assisted coronary angioplasty in Europe. The procedure was carried out by Prof. Eric Durand and Prof. Rémi Sabatier at the Rouen Medical Training Center and Caen University Hospital in ...
By Robocath
-
WHO/Europe Warn Extreme Heat on Health Impact
Heat can trigger exhaustion, confusion and even heart attacks, as well as worsen existing conditions, such as cardiovascular and respiratory diseases. The most vulnerable groups include elderly people, infants and children, people with lower socioeconomic status or chronic diseases, those taking certain medications and people in particular occupations outdoors (such as farming, construction, oil ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you